Evi Ratna Sari
Pusat Analisis Kebijakan Obat dan Makanan, Badan Pengawas Obat dan Makanan, Jakarta, Indonesia

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

Pengetahuan Masyarakat Terhadap Keamanan Obat Tradisional dan Risiko Bahan Kimia Obat di Indonesia Tina Wikara; Sri Astuti; Sri Nurhayati; Rotua Uli Carolina Simanjuntak; Evi Ratna Sari; Oktiva Rahmawati Dhewi
Jurnal Farmasi Indonesia Vol 18 No 2 (2026): Jurnal Farmasi Indonesia
Publisher : Pengurus Pusat Ikatan Apoteker Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.35617/jfionline.v18i2.791

Abstract

The use of traditional medicines in Indonesia is increasing, while some products still do not meet safety requirements and may contain chemical drug substances (CDS) that pose health risks. This situation requires adequate public knowledge in selecting traditional medicines that are safe and of good quality. This study aimed to assess the level of public knowledge in Indonesia regarding the safety of traditional medicines and understanding of the risks associated with CDS. A cross-sectional design was applied through a national survey conducted from July to September 2024, involving 20,610 respondents from 34 provinces using a stratified three-stage sampling method. The results showed that 74.24% of respondents had used traditional medicines in the past six months. Respondents’ knowledge of product safety indicators was in the good category, particularly regarding labels and expiration dates, while understanding of registration numbers was relatively lower. Knowledge about the risks of CDS content was still limited, with only 59.71% of respondents aware that traditional medicines may contain CDS and negatively affect health. Higher levels of knowledge were observed among women, individuals aged <35 years, urban residents, and respondents with higher educational attainment. There remains a gap in public knowledge in Indonesia regarding the safety of traditional medicines and the risks of BKO. More extensive and targeted public education efforts, along with strengthened regulatory oversight, are needed to prevent the circulation of traditional medicines containing CDS.